Related Experiment Video
Updated: Nov 3, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Acute Kidney Injury in Hospitalized Children with COVID19
Sanya Chopra1, Abhijeet Saha2, Virendra Kumar1
1Department of Paediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital, New Delhi 110001, India.
Insights
Acute kidney injury (AKI) significantly increases mortality risk in children with COVID-19, especially in resource-limited settings. Early kidney replacement therapy is crucial for reducing deaths in these vulnerable pediatric patients.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- Acute kidney injury (AKI) is a known risk factor for mortality in adults with severe acute respiratory syndrome coronavirus infection.
- Limited data exists on AKI prevalence and risk factors in pediatric COVID-19 patients, particularly in resource-limited settings.
Purpose of the Study:
- To determine the prevalence and identify risk factors for AKI in hospitalized children with COVID-19.
- To assess the impact of AKI on mortality in this pediatric population within a resource-limited environment.
Main Methods:
- A cross-sectional analysis of laboratory-confirmed COVID-19 pediatric cases admitted between March and November 2020.
- AKI staging was performed using the Kidney Disease Improving Global Outcomes (KDIGO) serum creatinine criteria.
- Univariate and Kaplan-Meier survival analyses were employed to evaluate outcomes.
Main Results:
- Of 105 hospitalized children, 22.8% developed AKI, with 37.5% in Stage 3.
- Risk factors for AKI included sepsis, nephrotic syndrome, vasopressor support, shock, and mechanical ventilation.
- Mortality was significantly higher in the AKI group (25.71%), with shock and ventilation being major contributors.
Conclusions:
- AKI is a critical, modifiable risk factor for mortality in pediatric COVID-19 patients in resource-limited settings.
- Strengthening kidney replacement therapy and ensuring its timely initiation are vital for improving survival rates.
Background:
Acute kidney injury (AKI) has been recognized as a significant risk factor for mortality among adults with severe acute respiratory syndrome coronavirus infection.
Aim:
The aim of this study is to assess the prevalence and risk factors for AKI and mortality in children with coronavirus disease 2019 (COVID19) from a resource-limited setting.
Methods:
Cross-sectional analysis of laboratory confirmed COVID19 children admitted from 1 March to 30 November 2020 in a tertiary care hospital in New Delhi, India was done. Clinical features and associated comorbidities of COVID19 were noted. Baseline serum creatinine (height-independent Hoste's equation) and peak serum creatinine were used for staging of AKI by the 2012 Kidney Disease Improving Global Outcomes serum creatinine criteria. Univariate analysis and Kaplan-Meier survival analysis were used to compare the overall outcome in the AKI vs. the non-AKI group.
Results:
A total of 64 810 children between 1 month and 18 years visited the hospital; 3412 were tested for suspected COVID19, 295 tested positive and 105 (54% boys) were hospitalized. Twenty-four hospitalized children (22.8%) developed AKI; 8 in Stage 1 (33.3%), 7 in Stage 2 (29.2%) and 9 in Stage 3 (37.5%) respectively. Overall, three patients received KRT. Highest reported mortality was (66.6%) in AKI Stage 3. Risk factors for AKI included associated sepsis (OR 95% CI, 1.22-9.43, p < 0.01), nephrotic syndrome (OR 95% CI, 1.13-115.5, p < 0.01), vasopressor support (OR 3.59, 95% CI, 1.37-9.40, p value< 0.007), shock at presentation (OR 2.98, 95% CI, 1.16-7.60, p value 0.01) and mechanical ventilation (OR 2.64, 95% CI, 1.04-6.71, p value< 0.03). Mortality (25.71%) was higher in the AKI group (OR 95% CI, 1.14-8.35, p < 0.023) with shock (OR 45.92; 95% CI, 3.44-612.0, p value <0.004) and ventilation (OR 46.24; 95% CI, 1.6-1333.0 p value< 0.02) as significant risk factors for mortality.
Conclusion:
AKI is an important modifiable risk factor for mortality in children with COVID19 in a resource-limited setting. Our study supports the strengthening of kidney replacement therapy and its timely initiation to reduce the progression of AKI and thus mortality in children.
More Related Videos
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

